ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Net Issuance of Debt
ADC Therapeutics SA
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Net Issuance of Debt
$-6.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Net Issuance of Debt
CHf-548k
|
CAGR 3-Years
17%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Net Issuance of Debt
CHf-59.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Net Issuance of Debt
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Net Issuance of Debt
CHf-482k
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Net Issuance of Debt?
Net Issuance of Debt
-6.5m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Net Issuance of Debt amounts to -6.5m USD.
What is ADC Therapeutics SA's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
0%
Over the last year, the Net Issuance of Debt growth was 0%.